What is the recommended dose of intravenous (IV) midazolam in pediatric patients based on weight?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Weight-Based Intravenous Midazolam Dosing in Pediatric Patients

For intravenous midazolam in children, administer 0.05-0.10 mg/kg over 2-3 minutes for sedation/anxiolysis (maximum single dose: 5 mg), with younger children requiring higher mg/kg doses than older children and adolescents. 1, 2

Age-Stratified Dosing Recommendations

Infants <6 Months

  • Initial dose: 0.05-0.1 mg/kg IV over 2-3 minutes 2
  • This age group is particularly vulnerable to airway obstruction and hypoventilation 2
  • Titrate with small increments and monitor continuously 2
  • Limited safety data exists for this population 2

Children 6 Months to 5 Years

  • Initial dose: 0.05-0.1 mg/kg IV over 2-3 minutes 1, 2, 3
  • Total dose may reach up to 0.6 mg/kg to achieve desired effect (usually not exceeding 6 mg) 2, 3
  • This age group typically requires the highest mg/kg doses compared to older children 1, 4
  • Mean doses in toddlers have been documented at 0.26 ± 0.13 mg/kg 4

Children 6 to 12 Years

  • Initial dose: 0.025-0.05 mg/kg IV over 2-3 minutes 2, 3
  • Total dose up to 0.4 mg/kg may be needed (usually not exceeding 10 mg) 2, 3
  • Higher doses are associated with prolonged sedation and increased hypoventilation risk 2

Adolescents 12-16 Years

  • Dose as adults: 1-2 mg IV initially 2
  • Some patients may require higher than adult doses, but total usually does not exceed 10 mg 2
  • Mean doses in adolescents documented at 0.09 ± 0.06 mg/kg 4

Critical Titration Protocol

Wait 3-5 minutes between doses to assess peak effect before redosing 1, 2. Midazolam takes approximately three times longer than diazepam to achieve peak EEG effects due to its water solubility 2. Failure to wait adequate time between doses is a common cause of oversedation 1.

Redosing Strategy

  • After initial dose, observe for 3-5 minutes 1
  • If additional sedation needed, give incremental doses of 1 mg (or 0.2-0.3 mg/kg in smaller children) 1
  • Continue titrating at 2-minute intervals until desired effect achieved 1, 2

Special Clinical Situations

Rapid Sequence Intubation

  • Dose: 0.2 mg/kg IV 1
  • Allow 2-3 minutes for effect before administering muscle relaxant 1
  • Lower doses are ineffective for RSI 1

Refractory Status Epilepticus

  • Loading dose: 0.15-0.20 mg/kg IV 1
  • Follow with continuous infusion starting at 1 μg/kg/min, titrating up to maximum 5 μg/kg/min 1

When Combined with Opioids

  • Reduce midazolam dose by 50% or more 1, 2
  • Synergistic respiratory depression occurs when combined with fentanyl or other opioids 1, 4
  • In one study, 26% of children with normal lungs developed oxygen desaturation (as low as 65%) when midazolam was combined with opioids 4

Mandatory Safety Monitoring

Continuous pulse oximetry is non-negotiable 1, 5. Oxygen desaturation occurred in 11.6% of pediatric patients receiving midazolam for procedural sedation 5.

Required Equipment and Personnel

  • Resuscitation equipment including bag-valve-mask and supplemental oxygen 6
  • Flumazenil (0.01 mg/kg) immediately available to reverse life-threatening respiratory depression 1, 5
  • Personnel trained in pediatric airway management present throughout sedation 5
  • Suction equipment readily accessible 6

Warning Signs Requiring Intervention

  • Respiratory rate <10 breaths/minute or irregular pattern 4
  • Oxygen saturation <90% 4
  • Airway obstruction (occurred in 3% of cases in one series) 4
  • Paradoxical agitation, particularly in children <6 years 1, 2

Critical Pitfalls to Avoid

Never administer midazolam as a rapid IV bolus - always give over 2-3 minutes to prevent respiratory depression and hypotension 1, 2.

Do not combine with other sedatives without appropriate monitoring capabilities - the American Academy of Pediatrics specifically warns of significantly increased apnea risk when midazolam is combined with opioids 5.

In obese children, calculate dose based on ideal body weight, not actual weight 2.

Flumazenil reverses both sedation AND anticonvulsant effects - if midazolam was used for seizure control, flumazenil may precipitate seizure recurrence 1, 5.

Dose Adjustments for High-Risk Patients

Elderly or ASA Class ≥3

  • Reduce dose by 20% or more 1
  • Clearance is reduced in patients with hepatic or renal impairment 1

Patients with Respiratory Disease

  • Start at lower end of dosing range 1
  • Respiratory depression is dose-dependent and results from depression of central ventilatory response to hypoxia and hypercapnea 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Intranasal Midazolam Dosing for Pediatric Sedation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Intranasal Midazolam Dosing for Procedural Sedation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the recommended dose of midazolam (Benzodiazepine) for pediatric sedation?
What is the maximum dose of midazolam (Benzodiazepine) for a 13-year-old pediatric patient?
What is the recommended dose of midazolam (a benzodiazepine) for a pediatric patient undergoing a sedative procedure?
What is the recommended dose of midazolam (intranasal midazolam) for sedation in pediatric patients?
What is the recommended dose of Versed (midazolam) for an 11-year-old before a procedure?
Should a patient with community-acquired pneumonia (CAP) on day 6 of antibiotic treatment continue therapy and if so, for how many more days?
What is the recommended initial dosing and titration schedule for Valproic acid (valproate) in an adult patient with epilepsy, bipolar disorder, or migraine headaches, considering potential hepatotoxicity, renal impairment, and blood dyscrasias?
What is the best course of action for a female patient of reproductive age with an ectopic pregnancy, who has been treated with methotrexate (methotrexate) and has rising beta-human chorionic gonadotropin (beta-hCG) levels from 1000 at baseline to 2100 on the 7th day?
What is the recommended daily dose of valproic acid (valproate) for a patient with bipolar disorder?
What is the proper technique for injecting Mounjaro (tirzepatide) in a patient with type 2 diabetes?
What are the benefits of using methylprednisolone (corticosteroid) versus hydrocortisone (corticosteroid) in patients with Henoch-Schonlein purpura (HSP) presenting with abdominal pain and hematemeses?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.